Neelakantan et al., NNMT inhibition reverses diet-induced obesity in mice (2018) Babula et al., NNMT inhibition mitigates obesity-related metabolic dysfunction: fat mass, glucose tolerance, hepatic steatosis, pharmacokinetics and off-target screen (Diabetes Obes Metab, 2024) Dimet-Wiley et al., NNMT inhibition mimics and boosts exercise-mediated muscle improvements in aged mice (Sci Rep, 2024) NNMT inhibition and muscle function in aged mice (2019) Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice (2022): the diet-switch combination study Awosemo et al., rat pharmacokinetics of 5-amino-1MQ (2021) NNMT in metabolism and disease: review Sigma-Aldrich: 5-Amino-1MQ iodide product data (CAS 42464-96-0) FDA: bulk drug substances used in compounding under section 503A Disclaimer: Informational and research purposes only, not medical advice
Bringing levels back within a healthy range allows the body to process macronutrients more efficiently
At 0.5mg per week, 10 weeks
Tirzepatide, the active ingredient in the Eli Lilly and Companys trademarked Zepbound, was already approved to help improve blood sugar (glucose) in adults with type 2 diabetes mellitus
Cellular GSH (cytosol, mitochondria, endoplasmic reticulum, nucleus
Anemia develops from B12 deficiency, as the vitamin is engaged in the production of healthy red blood cells
